Azagly-nafarelin: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 26: | Line 26: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Azagly-nafarelin.svg|Azagly-nafarelin | |||
</gallery> | |||
Latest revision as of 00:45, 20 February 2025
Azagly-nafarelin is a gonadotropin-releasing hormone agonist (GnRH agonist) that was never marketed. It is a synthetic decapeptide and is used in scientific research.
Etymology[edit]
The term "Azagly-nafarelin" is derived from the chemical structure of the compound. "Aza" refers to the presence of a nitrogen atom, "gly" is short for glycine, and "nafarelin" is a type of GnRH agonist.
Pharmacology[edit]
Azagly-nafarelin is a type of GnRH agonist. GnRH agonists are drugs that act on the gonadotropin-releasing hormone receptor. They are used to control the production of sex hormones in the body, and can be used to treat a variety of conditions, including endometriosis, uterine fibroids, and prostate cancer.
Chemical Structure[edit]
Azagly-nafarelin is a synthetic decapeptide, which means it is made up of ten amino acids. The specific sequence of amino acids in azagly-nafarelin gives it its unique properties as a GnRH agonist.
Use in Research[edit]
While azagly-nafarelin was never marketed as a drug, it is used in scientific research. Researchers use it to study the effects of GnRH agonists on the body, and to develop new treatments for conditions that are affected by sex hormone levels.
See Also[edit]
- Gonadotropin-releasing hormone
- Gonadotropin-releasing hormone receptor
- Gonadotropin-releasing hormone agonist
References[edit]
<references />


